Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: Data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registry

Canadian Journal of Cardiology

Volumn 25, Issue 9, 2009, Pages S306-S311

  Howlett, Jonathan G ^a   Mann, O Elizabeth ^a   Baillie, Robert ^b   Hatheway, Ronald ^c   Svendsen, Anna ^a   Benoit, Rosalind ^a   Ferguson, Carol ^b   Wheatley, Marlene ^c   Johnstone, David E ^a   Cox, Jafna L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Cape Breton Regional Hospital   (Australia)

^c South Shore Regional Hospital   (Canada)

Author keywords

Disease management; Heart failure; Morbidity; Mortality; Outcomes

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CANADA; COMMUNITY CARE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEALTH CENTER; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; TRANSIENT ISCHEMIC ATTACK; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; HEALTH CARE QUALITY; HOSPITAL; HOSPITAL ADMISSION; LENGTH OF STAY; MORBIDITY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PROSPECTIVE STUDY; REGISTER; STATISTICS;

AGED; COMMUNITY HEALTH CENTERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALS, SPECIAL; HUMANS; LENGTH OF STAY; MALE; MORBIDITY; NOVA SCOTIA; PATIENT ADMISSION; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES;

EID: 70349569988     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0828-282x(09)70141-2     Document Type: Article

References (30)

1. (Version current at July 16, 2009).
2. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001;104:2996-3007.
3. Funk M, Krumholz HM. Epidemiologic and economic impact of advanced heart failure. J Cardiovasc Nuts 1996;10:1-10.
4. Johansen H, Strauss B, Arnold JM, Moe G, Liu P. On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 2003;19:430-5.
5. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J ?004;25:300-7.
6. Lee DS, Mamdani MM, Austin PC, et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med 2004;116:581-9.
7. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.
8. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: Relation to practice guidelines. J Am Coll Cardiol 1997;30:518-26.
9. Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RL Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000;139:72-7.
10. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intem Med 1988; 148:2013-6.
11. Gustafsson F, Arnold JM. Heart failure clinics and outpatient management: Review of the evidence and call for quality assurance. Eur Heart J 2004;25:1596-604.
12. Heidenreich PA, Ruggerio CM, Massie BM. Effect of a home monitoring system on hospitalization and resource use for patients with heart failure. Am Heart J 1999;138:63340.
13. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002;39:83-9.
14. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
15. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: Long-term implications on readmission and survival. Circulation 2002;105:2861-6.
16. Cox JL, Zitner D, Courtney KD, et al. Undocumented patient information: An impediment to quality of care. Am J Med 2003;114:211-6.
17. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: Who are these patients and how did they get there? Ann Intern. Med 2002;137:10-6.
18. Howlett JG, Johnstone DE, Sketris I, O'Reilly M, Home GS, Cox JL. Identifying opportunities to address the congestive heart failure burden: The Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol 2003; 19:439-44.
19. Cox JL. Optimizing disease management at a health care system level: The rationale and methods of the improving cardiovascular outcomes in Nova Scotia (ICONS) study. Can J Cardiol 1999;15:787-96.
20. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern. Med 1990;150:769-73.
21. Joshi AV, D'Souza AO, Madhavan SS. Differences in hospital length-of-stay, charges, and mortality in congestive heart failure patients. Congest Heart Fail 2004;10:76-84.
22. Phillips CO, Wright SM, Kem DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: A meta-analysis. JAMA 2004;291:1358-67.
23. Bozkurt B, Agoston I, Knowlton AA. Complications of inappropriate use of spironolactone in heart failure: When an old medicine spirals out of new guidelines. J Am Coll Cardiol 2003;41:211-4.
24. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
25. Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail 2004;10:297-303.
26. Shah BR, Laupacis A, Hux X Austin PC. Propensity score methods gave similar results to traditional regression modeling in observational studies: A systematic review. J Clin Epidemiol 2005;58:550-9.
27. Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med 1995;122:415,21.
28. Foody JM, Rathore SS, Wang Y, et al. Predictors of cardiologist care for older patients hospitalized for heart failure. Am Heart J 2004;147:66-73.
29. Howlett JG, Cox JL, Haddad H, Stanley J, McDonald M, Johnstone DE. Physician specialty and quality of care for CHF: Different patients or different patterns of practice? Can J Cardiol 2003;19:371-7.
30. Gregory PM, Malka ES, Kostis JB, Wilson AC, Arora JK, Rhoads GG. Impact of geographic proximity to cardiac revascularization services on service utilization. Med Care 2000;38:45-57.